Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.
Frequently asked questions
What sector does Bonraybio Co., Ltd. (6955) operate in?
Bonraybio Co., Ltd. belongs to the Other sector and operates in the Medical Devices industry.
What is Bonraybio Co., Ltd. (6955) current stock price?
As of the latest data, Bonraybio Co., Ltd. stock price is NT$125.50, with a previous close of NT$125.00. Bonraybio Co., Ltd. gained NT$0.50 in the last trading session, representing a 0.4% increase.
What is Bonraybio Co., Ltd. (6955) current market capitalization?
Bonraybio Co., Ltd. market cap is approximately 3.11 billion.
What is Bonraybio Co., Ltd. (6955) Earnings Per Share (EPS)?
The trailing EPS is NT$4.12.
What is Bonraybio Co., Ltd. (6955) Price-to-Earnings (P/E) ratio?
Bonraybio Co., Ltd. current P/E ratio is 30.46.
Does Bonraybio Co., Ltd. (6955) pay dividends?
Yes. Bonraybio Co., Ltd. pays semiannual dividends with an annualized yield of 2.39% and an estimated annual payout of NT$3.00 per share.
When is the next ex-dividend date for Bonraybio Co., Ltd. (6955)?
The next ex-dividend date is scheduled for September 19, 2026.
What is Bonraybio Co., Ltd. (6955) beta (volatility) score?
Bonraybio Co., Ltd. has a beta of 0.029, indicating lower volatility than the overall market.
